Finucane Anne A.
Known title: DirectorCIK: 0001511491
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
Transaction History
| WSM | ▲ Buy | Option Exercise | 162 | $0 | 6/18/2026 | View on chart |
| WSM | ▲ Buy | Option Exercise | 148 | $0 | 6/18/2026 | View on chart |
| WSM | ▲ Buy | Option Exercise | 171 | $0 | 6/18/2026 | View on chart |
| WSM | ▲ Buy | Option Exercise | 109 | $0 | 6/18/2026 | View on chart |
| WSM | ▲ Buy | Option Exercise | 1,280 | $0 | 6/11/2026 | View on chart |
| CVS | ▲ Buy | Grant | 591 | $45K | 11/20/2025 | View on chart |
| CVS | ▼ Sell | Open Market | 7,500 | $533K | 8/20/2025 | View on chart |
| WSM | ▲ Buy | Option Exercise | 1,424 | $0 | 5/29/2025 | View on chart |
| CVS | ▲ Buy | Grant | 692 | $42K | 5/15/2025 | View on chart |
| CVS | ▼ Sell | Gift | 2,665 | $152K | 12/5/2024 | View on chart |
| WSM | ▼ Sell | Gift | 820 | $0 | 12/5/2024 | View on chart |
| WSM | ▲ Buy | Option Exercise | 30 | $0 | 5/28/2024 | View on chart |
| WSM | ▲ Buy | Option Exercise | 1,468 | $0 | 5/28/2024 | View on chart |
| WSM | ▲ Buy | Grant | 110 | $0 | 1/29/2024 | View on chart |
| CVS | ▼ Sell | Gift | 3,450 | $256K | 12/7/2023 | View on chart |
| CVS | ▲ Buy | Grant | 1,925 | $133K | 11/15/2023 | View on chart |
| WSM | ▲ Buy | Grant | 145 | $0 | 10/30/2023 | View on chart |
| WSM | ▲ Buy | Grant | 151 | $0 | 7/31/2023 | View on chart |
| WSM | ▲ Buy | Option Exercise | 1,328 | $0 | 5/30/2023 | View on chart |
| CVS | ▲ Buy | Grant | 1,437 | $100K | 5/18/2023 | View on chart |
| WSM | ▲ Buy | Grant | 175 | $0 | 5/1/2023 | View on chart |
| CVS | ▼ Sell | Gift | 800 | $78K | 11/18/2022 | View on chart |
| CVS | ▲ Buy | Grant | 1,428 | $136K | 11/17/2022 | View on chart |
| WSM | ▲ Buy | Option Exercise | 455 | $0 | 5/31/2022 | View on chart |
| CVS | ▲ Buy | Grant | 1,384 | $136K | 5/11/2022 | View on chart |
| CVS | ▲ Buy | Grant | 1,314 | $122K | 11/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
WSM trades near 52-week high with elevated RSI
Williams-Sonoma shares are currently trading near the top of their 52-week range, with the RSI indicator showing a value of 69.5. This suggests the stock has seen strong recent momentum, though it is approaching levels often associated with overbought conditions. The company maintains a trailing P/E ratio of 23.6 and a dividend yield of 1.58%, while analysts hold an average price target of $246.35.
WSM trades near 52-week high with elevated RSI. Williams-Sonoma shares are currently trading near the top of their 52-week range, with the RSI indicator showing a value of 69.5. This suggests the stock has seen strong recent momentum, though it is approaching levels often associated with overbought conditions. The company maintains a trailing P/E ratio of 23.6 and a dividend yield of 1.58%, while analysts hold an average price target of $246.35.